Study protocol of short versus long-term levetiracetam in brain tumors (LIBRA): a phase 3 randomized controlled trial

Abstract Background Seizures are common in patients with brain tumors, impacting daily life and healthcare burden. In contemporary neuro-oncology practice, levetiracetam is the most commonly prescribed anti-seizure medication (ASM). Although the practice is widely variable, levetiracetam is usually...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Archya Dasgupta, Shakthivel Mani, Abhishek Chatterjee, Sadhana Kannan, Aliasgar Moiyadi, Prakash Shetty, Vikas Singh, Nandini Menon, Arpita Sahu, Amitkumar Choudhary, Kajari Bhattacharya, Ameya Puranik, Indraja Dev, Sridhar Epari, Ayushi Sahay, Aekta Shah, Nazia Bano, Farnaz Shaikh, Tejpal Gupta
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2025-05-01
Schriftenreihe:	BMC Cancer
Schlagworte:	Seizures Levetiracetam Brain tumor Antiepileptics Glioma
Online-Zugang:	https://doi.org/10.1186/s12885-025-14305-7
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!